“fda” Archives

in
Entry Author Date Location
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug 05/30/17 San Diego
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug 05/30/17 San Francisco
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Amid Budget Concerns, NIH Preps Beta Test for Precision Medicine Plan 05/25/17 National
Unconventional Partners, Like FDA, Can Drive Adoption of New Tech 05/24/17 Boston
Gottlieb Says FDA’s “Regulatory Tools” Can Help Fight Opioid Abuse 05/23/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product 05/23/17 San Diego
Cook Medical Gets FDA OK for Device to Treat Rare Birth Defect 05/22/17 Indiana
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
Senate Vote Confirms Scott Gottlieb for FDA Commissioner 05/09/17 National
Analysts Expect Payer Pushback as PTC Sets $35K Price For Duchenne Drug 05/08/17 New York
VenBio Settles Immunomedics Litigation, SeaGen Nixes Cancer Drug Deal 05/05/17 New York
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
Keeping Focus on Cancer, Karyopharm Licenses Antiviral to Anivive 05/04/17 Boston
Pieris Adds Another Partner, Gets $45M in AstraZeneca Lung Drug Deal 05/03/17 Boston
Shire Sets Sights on Dry Eye Disease with Deal for Parion Drug 05/01/17 Boston
Texas Roundup: Joshua Baer, UTD, Prytime, Next Coast, Spanning 05/01/17 Texas
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Radius Nabs FDA OK For New Bone Drug With Rival Amgen Close Behind 04/28/17 Boston
After Sarepta’s Surprising FDA Nod, CEO Kaye Plans to Resign 04/28/17 Boston
FDA Approves BioMarin Drug, A First for Rare Genetic Batten Disease 04/27/17 San Francisco
Page 4 of 63 « previous page · next page »